Postmenopausal Osteoporosis
- 1 May 1988
- journal article
- research article
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 81 (5), 597-600
- https://doi.org/10.1097/00007611-198805000-00014
Abstract
Eleven menopausal patients were treated for 12 to 18 months with low-dose sodium fluoride and calcium. Six patients also recieved estrogen replacement. A significant increase in spine or hip bone mineral density measured by dual photon absorptiometery was observed in all patients. The estrogen-treated group had the greatest increase in bone density. Addition of estrogen seems to supplement bone gain and allow sodium fluoride to be administered in lower doses, which are easily tolerated and yet effective.This publication has 6 references indexed in Scilit:
- Dual-photon Gd-153 absorptiometry of bone.Radiology, 1985
- Effect of the Fluoride/Calcium Regimen on Vertebral Fracture Occurrence in Postmenopausal OsteoporosisNew England Journal of Medicine, 1982
- Three-Year Changes in Bone Mineral Mass of Postmenopausal Osteoporotic Patients Based on Neutron Activation Analysis of the Central Third of the Skeleton*Journal of Clinical Endocrinology & Metabolism, 1981
- Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis.JCI Insight, 1981
- Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrenceJAMA, 1980
- The Effects of Sodium Fluoride on Calcium Metabolism of Subjects with Metabolic Bone Diseases*JCI Insight, 1964